Prothena Corp. Plc (PRTA)

9.40
NASDAQ : Health Technology
Prev Close 9.96
Day Low/High 9.37 / 9.98
52 Wk Low/High 8.63 / 15.91
Avg Volume 286.80K
Exchange NASDAQ
Shares Outstanding 39.87M
Market Cap 397.06M
EPS -3.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Watch the Dollar and Supply

The weak dollar was the breeze that pushed the market higher.

Backing Away From Biotechs

This sector could see some real damage.

Prothena (PRTA) Is Today's Perilous Reversal Stock

Prothena (PRTA) Is Today's Perilous Reversal Stock

Trade-Ideas LLC identified Prothena (PRTA) as a "perilous reversal" (up big yesterday but down big today) candidate

Biotech Stocks at a Crossroad

Own them, or take something off the table?

Jim Cramer's Top Takeaways: Papa Murphy's, Nike, Prothena

Jim Cramer's Top Takeaways: Papa Murphy's, Nike, Prothena

Cramer is excited by Papa Murphy's business model while Prothena could have a hit with its Parkinson's drug.

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Cramer says it's time to take some profits and raise cash for the next speed bump. He'll be watching company earnings from Sonic, Paychex and GameStop, among others.

Cramer -- 'It's OK to Be Careful' With Biotech Stocks After Big Rally

Cramer -- 'It's OK to Be Careful' With Biotech Stocks After Big Rally

TheStreet's Jim Cramer still likes biotech stocks, which have risen thanks in part to good news from several clinical trials, but he suggests caution after the sector's recent moves higher.

Prothena (PRTA) Moving On Heavy Volume In The Pre-Market Hours

Prothena (PRTA) Moving On Heavy Volume In The Pre-Market Hours

Trade-Ideas LLC identified Prothena (PRTA) as a pre-market mover with heavy volume candidate

These Stocks Get Benefit of the Doubt

Market backtracks on skepticism over biotechs.

Two Small-Cap Biotechs To Consider

Two Small-Cap Biotechs To Consider

Fibrocell Science and Prothena have several 'shots on goal.'

Commit To Purchase Prothena Corp At $17.50, Earn 33.1% Annualized Using Options

Commit To Purchase Prothena Corp At $17.50, Earn 33.1% Annualized Using Options

Investors considering a purchase of Prothena Corp plc shares, but tentative about paying the going market price of $17.97/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the June 2015 put at the $17.50 strike, which has a bid at the time of this writing of $3.00.

Prothena is Now Oversold (PRTA)

Prothena is Now Oversold (PRTA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Prothena (PRTA) Is Today's Pre-Market Mover With Heavy Volume Stock

Prothena (PRTA) Is Today's Pre-Market Mover With Heavy Volume Stock

Trade-Ideas LLC identified Prothena (PRTA) as a pre-market mover with heavy volume candidate

TheStreet Quant Rating: D (Sell)